|
AVRO
|
AVROBIO, Inc.
|
US
|
NASDAQ
|
|
BLUE
|
bluebird bio, Inc.
|
US
|
NASDAQ
|
|
DSGN
|
Design Therapeutics, Inc.
|
US
|
NASDAQ
|
|
DYN
|
Dyne Therapeutics, Inc.
|
US
|
NASDAQ
|
|
EVAX
|
Evaxion Biotech A/S
|
US
|
NASDAQ
|
|
FDMT
|
4D Molecular Therapeutics, Inc.
|
US
|
NASDAQ
|
|
FIXX
|
Homology Medicines, Inc.
|
US
|
NASDAQ
|
|
FLGT
|
Fulgent Genetics, Inc.
|
US
|
NASDAQ
|
|
FRLN
|
Freeline Therapeutics Holdings plc
|
US
|
NASDAQ
|
|
GNPX
|
Genprex, Inc.
|
US
|
NASDAQ
|
|
IDXG
|
Interpace Diagnostics Group, Inc.
|
US
|
NASDAQ
|
|
IDYA
|
IDEAYA Biosciences, Inc.
|
US
|
NASDAQ
|
|
LOGC
|
LogicBio Therapeutics, Inc.
|
US
|
NASDAQ
|
|
MDXH
|
MDxHealth SA
|
US
|
NASDAQ
|
|
ME
|
23andMe Holding Co.
|
US
|
NASDAQ
|
|
MYGN
|
Myriad Genetics, Inc.
|
US
|
NASDAQ
|
|
MYNZ
|
Mainz Biomed B.V.
|
US
|
NASDAQ
|
|
NTRA
|
Natera, Inc.
|
US
|
NASDAQ
|
|
NVTA
|
Invitae Corporation
|
US
|
NYSE
|
|
PRE
|
Prenetics Global Limited
|
US
|
NASDAQ
|